Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Addendum: The antibody aducanumab reducesplaques in Alzheimer's disease.

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A.

Nature. 2017 Jun 21;546(7659):564. doi: 10.1038/nature22809.

PMID:
28640269
2.

Aducanumab reducesplaques in Alzheimer's disease.

Vaillancourt DE.

Mov Disord. 2016 Nov;31(11):1631. doi: 10.1002/mds.26833. Epub 2016 Oct 14. Review. No abstract available.

PMID:
27739124
3.

The antibody aducanumab reducesplaques in Alzheimer's disease.

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A.

Nature. 2016 Sep 1;537(7618):50-6. doi: 10.1038/nature19323. Update in: Nature. 2017 Jun 21;546(7659):564.

PMID:
27582220

Supplemental Content

Loading ...
Support Center